Courtney Marabella | Authors

Treatment with Pembrolizumab/Chemo Combo May Be a Standard of Care in mTNBC

December 07, 2021

Patients with previously untreated, locally recurrent, inoperable, or metastatic triple-negative breast cancer derived a statistically significant survival benefit following treatment with pembrolizumab and chemotherapy.